Bone regeneration using a synthetic matrix containing enamel matrix derivate.

Area of Science:

• Biomaterials science
• Regenerative medicine
• Oral and maxillofacial surgery

Background:

• Enamel matrix derivative (EMD) is utilized for periodontal regeneration.
• Synthetic polyethylene glycol (PEG)-based hydrogels offer tunable properties for drug delivery.
• RGD sequences can promote cell adhesion and tissue regeneration.

Purpose of the Study:

• To evaluate the efficacy of EMD delivered via PEG-hydrogels, with and without RGD peptides, in enhancing bone formation in vivo.
• To compare the effects of different EMD concentrations and RGD peptide inclusion on bone regeneration.

Main Methods:

• A rabbit calvarial defect model was used with titanium cylinders.
• Four treatment groups were established: control (empty), EMD (100 μg/ml), EMD (500 μg/ml), and EMD (500 μg/ml) with RGD peptide, all within a PEG-HA/TCP matrix.
• Histomorphometric analysis was performed after 8 weeks, with statistical analysis using the Kruskal-Wallis test.

Main Results:

• The EMD 500/RGD group showed a significantly larger area fraction of newly formed bone compared to control and EMD 500 groups.
• The EMD 500/RGD group demonstrated a non-significantly higher bone area fraction compared to the EMD 100 group.
• No statistically significant differences were observed in the percentage of mineralized bone or bone-to-graft contact among the treatment groups.

Conclusions:

• PEG-hydrogel delivery of EMD combined with HA/TCP granules did not influence mineralized bone formation.
• The addition of RGD peptide to the PEG/EMD 500 combination significantly increased newly formed bone area.
• Further research is warranted to explore potential synergistic effects between EMD and RGD peptides in bone regeneration.